Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.

Main|Search|PHGKB


Last Posted: Jul 13, 2018

---

• Richard Smith: Is precision medicine a fantasy?  
  R Smith, BMJ, July 13, 2018
• Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.  
  Issa Amalia M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jul
• Bringing Us Closer to Understanding Health and Disease at an Individual Level  
  E Ramos. ASHG Blog, July 2018
• Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients.  
  Cabanillas Rubén et al. BMC medical genomics 2018 Jul 11(1) 58
• Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine.  
  McLean Anna E B et al. Journal of clinical medicine 2018 Jun 7(7)
• Editorial: Turning Point towards Blood Biomarker-Guided Targeted Therapy for Precision Medicine in Alzheimer's disease.  
  Hampel H et al. The journal of prevention of Alzheimer's disease 2018 5(3) 160-164
• Efficacy of the MDM2 inhibitor SAR405838 in glioblastoma is limited by poor distribution across the blood-brain barrier.  
  Kim Minjee et al. Molecular cancer therapeutics 2018 Jul
• Knowledge-for-data trade at the interface between precision medicine and person-centered care.  
  Gajovic Srecko et al. Croatian medical journal 2018 Jun 59(3) 132-135
• New Horizons for Precision Medicine in Biliary Tract Cancers.  
  Valle Juan W et al. Cancer discovery 2017 7(9) 943-962
• Precision medicine applications in prostate cancer.  
  McCrea Edel M et al. Therapeutic advances in medical oncology 2018 101758835918776920

more